Zur Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt wechseln

Effects of Smoking Cessation on Presynaptic Dopamine Function of Addicted Male Smokers

Lena Rademacher*, Susanne Prinz, Oliver Winz, Karsten Henkel, Claudia A. Dietrich, Jörn Schmaljohann, Siamak Mohammadkhani Shali, Ina Schabram, Christian Stoppe, Paul Cumming, Ralf Dieter Hilgers, Yoshitaka Kumakura, Mark Coburn, Felix M. Mottaghy, Gerhard Gründer, Ingo Vernaleken

*Korrespondierende/r Autor/-in für diese Arbeit

Abstract

Background There is evidence of abnormal cerebral dopamine transmission in nicotine-dependent smokers, but it is unclear whether dopaminergic abnormalities are due to acute nicotine abuse or whether they persist with abstinence. We addressed this question by conducting longitudinal positron emission tomography (PET) examination of smokers before and after 3 months of abstinence. Methods We obtained baseline 6-[ 18 F]fluoro-L-DOPA (FDOPA)-PET scans in 15 nonsmokers and 30 nicotine-dependent smokers, who either smoked as per their usual habit or were in acute withdrawal. All smokers then underwent cessation treatment, and successful abstainers were re-examined by FDOPA-PET after 3 months of abstinence (n = 15). Uptake of FDOPA was analyzed using a steady-state model yielding estimates of the dopamine synthesis capacity (K); the turnover of tracer dopamine formed in living brain (k loss ); and the tracer distribution volume (V d ), which is an index of dopamine storage capacity. Results Compared with nonsmokers, K was 15% to 20% lower in the caudate nuclei of consuming smokers. Intraindividual comparisons of consumption and long-term abstinence revealed significant increases in K in the right dorsal and left ventral caudate nuclei. Relative to acute withdrawal, V d significantly decreased in the right ventral and dorsal caudate after prolonged abstinence. Severity of nicotine dependence significantly correlated with dopamine synthesis capacity and dopamine turnover in the bilateral ventral putamen of consuming smokers. Conclusions The results suggest a lower dopamine synthesis capacity in nicotine-dependent smokers that appears to normalize with abstinence. Further investigations are needed to clarify the role of dopamine in nicotine addiction to help develop smoking prevention and cessation treatments.

OriginalspracheEnglisch
ZeitschriftBiological Psychiatry
Jahrgang80
Ausgabenummer3
Seiten (von - bis)198-206
Seitenumfang9
ISSN0006-3223
DOIs
PublikationsstatusVeröffentlicht - 01.08.2016

Fördermittel

This work was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft) Grant Nos. GR 1399/7-1 and SPP 1226. GG has served as a consultant for Bristol-Myers Squibb, Cheplapharm, Eli Lilly and Company, Forest Laboratories, Lundbeck, Otsuka, Roche, Servier, and Takeda; has served on the speakers’ bureau of Bristol-Myers Squibb, Eli Lilly and Company, Gedeon Richter, Otsuka, Roche, and Servier; has received grant support from Alkermes, Bristol-Myers Squibb, Eli Lilly and Company, and Roche; and is cofounder of Pharma-Image Molecular Imaging Technologies GmbH and Brainfoods UG. The other authors report no biomedical financial interests or potential conflicts of interest. Appendix A

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

  1. SDG 3 – Gesundheit und Wohlergehen
    SDG 3 – Gesundheit und Wohlergehen
  2. SDG 10 – Weniger Ungleichheiten
    SDG 10 – Weniger Ungleichheiten

Strategische Forschungsbereiche und Zentren

  • Forschungsschwerpunkt: Gehirn, Hormone, Verhalten - Center for Brain, Behavior and Metabolism (CBBM)

Fingerprint

Untersuchen Sie die Forschungsthemen von „Effects of Smoking Cessation on Presynaptic Dopamine Function of Addicted Male Smokers“. Zusammen bilden sie einen einzigartigen Fingerprint.

Zitieren